AVITA Medical, Inc. (RCEL) Misses Q2 EPS by 10c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q2 EPS of ($0.41), $0.10 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $11.75 million versus the consensus estimate of $11.3 million.

GUIDANCE:

AVITA Medical, Inc. sees Q3 2023 revenue of $13-14 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79